UBS/CALL/GALENICA/80.002/0.05/21.06.24 Stock

Warrant

BGAL4U

CH1170501584

Market Closed - Bid/Ask 11:20:00 2024-04-15 EDT			After market 23:55:01
0.017 ^CHF	-5.56%		0.015	-11.76%

3 months	-71.67%
6 months	-43.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart GALENICA AG

Chart UBS/CALL/GALENICA/80.002/0.05/21.06.24

Latest news about GALENICA AG

Switzerland's Galenica Issues CHF100 Million Bond Due 2031	04-17	MT
Galenica successfully places a bond of over CHF 100 million	04-16	EQ
7th Annual General Meeting: Shareholders approve all proposals	04-10	EQ
Galenica : Invitation to the 7th ordinary Annual General Meeting of Galenica Ltd.	03-19	PU

More news

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	GALENICA AG
Issuer	UBS
	BGAL4U
ISIN	CH1170501584
Date issued	2022-06-19
Strike	80 CHF
Maturity	2024-06-21 (40 Days)
Parity	20 : 1
Emission price	0.17 CHF
Emission volume	N/A
Settlement	physical
Currency	CHF

Technical Indicators

Highest since issue	0.45 CHF
Lowest since issue	0.017 CHF
Spread	0.01 CHF
Spread %	50.00%

Company Profile

Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.

Sector

More about the company